Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Fedratinib Induces Spleen Responses and Reduces Symptom Burden in MPN-Associated Myelofibrosis and Low Platelet Counts in Ruxolitinib Naïve or Patients Treated w/ Ruxolitinib

35 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login